-
England captain Stokes '100 percent to bowl' on return to cricket
-
Russia scolds ally Armenia for hosting Zelensky
-
France's far-right leaders court Israel, Germany envoys ahead of vote
-
Latest evacuee from hantavirus-hit cruise lands in Europe
-
Rubio meets US pope in bid to ease tensions
-
Women linked to IS fighters return to Australia from Middle East
-
Shell profit jumps as Mideast war fuels oil prices
-
Oil sinks, Tokyo leads Asia stock surge on growing Mideast peace hopes
-
India vows to crush terror 'ecosystem', a year after Pakistan conflict
-
Circus tackles jihadist nightmares of Burkina Faso's children
-
Iran denies ship attack as Trump warns of renewed bombing, eyes deal
-
Badminton looks to future with 'evolution and innovation'
-
Troubled waters: Jakarta battles deadly, invasive suckerfish
-
Senegal's children mourn in silence when migrant parents disappear
-
EU weighs options as summer jet fuel threat looms
-
Spurs thrash Timberwolves as Knicks edge Sixers in NBA playoffs
-
Australia to force gas giants to reserve fuel for domestic use
-
AirAsia signs $19bn deal for 150 Airbus A220 jets
-
Japan fires missiles during drills, drawing China rebuke
-
Toluca rout Son's LAFC to set up all-Mexican CONCACAF final
-
Vingegaard begins bid for Giro-Tour double with Pellizzari boosting home hopes
-
Roma's Champions League return back on as Milan, Juve wobble
-
Tokyo leads Asia stock surge on growing Mideast peace hopes
-
Australia cricket great Warner to 'accept' drink-drive charge: lawyer
-
Brunson steers Knicks to 2-0 lead with tight win over Sixers
-
Rubio seeks to ease tensions with US pope
-
AI disinfo tests South Korean laws ahead of local elections
-
Australian state overturns Melbourne ban on World Cup watch party
-
Colombian ex-fisherman swaps trade for saving Caribbean coral
-
Lobito Corridor: Africa's mega-project facing delivery test
-
Africa's Lobito Corridor chief tells AFP business, not geopolitics, drives strategy
-
Trump to host Lula in test of fitful relationship
-
K-pop stars BTS draw 50,000-strong crowd in Mexico
-
Britons set to punish Starmer's Labour in local polls
-
Wars in Middle East, backyard loom over ASEAN summit
-
US court releases purported Epstein suicide note
-
Israeli court rejects flotilla activists' appeal challenging detention
-
Polaris Renewable Energy Announces Q1 2026 Results
-
How to Clear the Strait of Hormuz from the Air: UMag Solutions Launches F1Mag(R) - an Unmanned Solution for Rapid Naval Mine Detection and Anti-Submarine Warfare
-
Victim's lawyer alleges Boeing was 'negligent' in 2019 Ethiopian crash
-
Williamson named in New Zealand squad for Ireland, England Tests
-
PSG add muscle to magic as another Champions League final beckons
-
Tigers' pitcher Valdez suspended for hitting opponent
-
Trump says Iran deal 'very possible' but threatens strikes if talks fail
-
Musk's SpaceX strikes data center deal with Anthropic
-
Bayern lament lack of 'killer' instinct after PSG elimination
-
Virus-hit cruise ship heads for Spain as evacuees land in Europe
-
Holders PSG edge Bayern Munich to reach Champions League final
-
Russia warns diplomats in Kyiv to evacuate in case of strike
-
Hantavirus ship passenger: 'They didn't take it seriously enough'
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
M.Odermatt--BTB